Five unit bolus oxytocin at cesarean delivery in women at risk of atony: A randomized, double-blind, controlled trial

Anesthesia and Analgesia

Volumn 111, Issue 6, 2010, Pages 1460-1466

  King, Kylie J ^a   Douglas, M Joanne ^b   Unger, Waldemar ^b   Wong, Areta ^a   King, Robert A R ^c  

^a JOHN HUNTER HOSPITAL   (Australia)

^b British Columbia Childrens Hospital   (Canada)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; SODIUM CHLORIDE; UTEROTONIC AGENT;

ADULT; ARTICLE; BLEEDING; CESAREAN SECTION; CLINICAL ASSESSMENT; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HEART RATE AND RHYTHM; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PLACENTAL DELIVERY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK FACTOR; SIDE EFFECT; TREATMENT OUTCOME; UMBILICAL CORD; UTERINE ATONY; VOMITING;

ADULT; BRITISH COLUMBIA; CESAREAN SECTION; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LOGISTIC MODELS; ODDS RATIO; OXYTOCICS; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREGNANCY; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SODIUM CHLORIDE; TIME FACTORS; TREATMENT OUTCOME; UTERINE CONTRACTION; UTERINE INERTIA;

EID: 78650305674     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181f8930a     Document Type: Article

References (33)

1. Thomas TA, Cooper GM. Anaesthesia. In: Lewis G, ed. Why Mothers Die 1997-1999: The fifth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. Lon-don: Royal College of Obstetricians and Gynaecologists' Press, 2001:134-49
2. National Collaborating Centre for Women's and Children's Health. Caesarean Section Clinical Guideline 2004. London: Royal College of Obstetricians and Gynaecologists' Press, 2004:11
3. Schuurmans N, MacKinnon C, Lane C, Etches D. Society of Obstetricians and Gynaecologists of Canada clinical practice guidelines: prevention and management of postpartum haem-orrhage. J SOCG 2000;88:1-11
4. Wedisinghe L, Macleod M, Murphy DJ. Use of oxytocin to prevent haemorrhage at caesarean section: a survey of practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol 2008;137:27-30
5. Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing caesarean section. Br J Anaesth 2007;98:116-9
6. Dennehy KC, Rosaeg OP, Cicutti NJ, Krepski B, Sylvain JP. Oxytocin injection after caesarean delivery: intravenous or intramyometrial? Can J Anaesth 1998;45:635-9
7. Pinder AJ, Dresner M, Calow C, O'Riordan J, Johnson R. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth 2002;11:156-9
8. Sartain JB, Barry JJ, Howat PW, McCormack DI, Bryant M. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective caesarean section. Br J Anaesth 2008;101:822-6
9. Langesaeter E, Rosseland LA, Stubhaug A. Haemodynamic effects of repeated doses of oxytocin during Caesarean deliv-ery in healthy parturients. Br J Anaesth 2009;103:260-2
10. Cotter AM, Ness A, Tolosa JE. Prophylactic oxytocin for the third stage of labour. Cochrane Database Syst Rev 2001: CD001808
11. Sarna MC, Soni AK, Gomez M, Oriol NE. Intravenous oxytocin in patients undergoing elective caesarean section. Anesth Analg 1997;84:753-6
12. Murphy DJ, MacGregor H, Munishankar B, McLeod G. A randomised controlled trial of oxytocin 5IU and placebo infu-sion versus oxytocin 5IU and 30IU infusion for the control of blood loss at elective caesarean section: pilot study. ISRCTN 40302163. Eur J Obstet Gynecol Reprod Biol 2009;142:30-3
13. Stotland NE, Caughey AB, Breed EM, Escobar GJ. Risk factors and obstetric complications associated with macrosomia. Int J Gynaecol Obstet 2004;87:220-6
14. Stones RW, Paterson CM, Saunders NJ. Risk factors for major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol 1993;48:15-8
15. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemor-rhage. Obstet Gynecol 2006;108:1039-47
16. Dildy GA. Postpartum hemorrhage: new management options. Clin Obstet Gynecol 2002;45:330-44
17. Mayer DC, Smith KA. Antepartum and postpartum hemor-rhage. In: Chestnut DH, Polley LS, Tsen LC, Wong CA, eds. Chestnut's Obstetric Anesthesia: Principles and Practice. 4th ed. Philadelphia: Elsevier Mosby, 2009:818
18. Combs CA, Murphy EL, Laros RK. Factors associated with hemorrhage in caesarean deliveries. Obstet Gynecol 1991;77: 77-82
19. Atkinson MW, Owen J, Wren A, Hauth JC The effect of manual removal of the placenta on post-cesarean endometritis. Obstet Gynecol 1996;87:99-102
20. Bickel PJ, Doksum KA. Mathematical Statistics. Oakland: Holden-Day, 1997
21. Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. Obstet Gynecol 2001;98:386-90
22. Hamm J, Russell Z, Botha T, Carlan SJ, Richichi K. Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study. Am J Obstet Gynecol 2005;192:1404-6
23. Good PI. Introduction to Statistics Through Resampling Meth-ods and R/S-PLUS. New York: Wiley, 2005
24. Danserau J, Joshi AK, Helewa ME, Doran TA, Lange IR, Luther ER, Farine D, Schulz ML, Horbay GL, Griffin P, Wassenaar W. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. Am J Obstet Gynecol 1999;180:670-6
25. Carvalho JCA, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose finding study. Obstet Gynecol 2004;104:1005-10
26. Balki M, Ronayne M, Davies S, Fallah S, Kingdom J, Windrin R, Carvalho JCA. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol 2006;107: 45-50
27. Acharya G, Al-Sammarai MT, Patel N, Al-Habib A, Kiserud T. A randomized, controlled trial comparing effect of oral miso-prostol and intravenous syntocinon on intra-operative blood loss during cesarean section. Acta Obstet Gynecol Scand 2001;80:245-50
28. Bayoumeu F, Baka NE, Fresson J, Monniero-Barbarino P. Do prophylactic prostaglandins reduce the transfusion rate at cesarean section in high-order multiple pregnancies? Eur J Obstet Gynecol Biol Reprod 2003;111:38-42
29. Larsson C, Saltvedt S, Wiklund I, Pahlen S, Andolf E. Estima-tion of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggeration. Acta Obstet Gynecol Scand 2006;85:1448-52
30. Pritchard JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology 1965;26:393-9
31. Bland JM, Bland DG. Statistics notes: one and two sided tests of significance. BMJ 1994;309:248
32. Svanström MC, Biber B, Hanes M, Johansson G, Näslund U, Bålfors EM. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during caesarean section. Br J Anaesth 2008;100:683-9
33. Davies GAL, Tessier JL, Woodman MC, Lipson A, Hahn PM. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial. Obstet Gynecol 2005;105:294-9